Rik J. Deitsch - Nov 15, 2021 Form 5 Insider Report for NUTRA PHARMA CORP (NPHC)

Role
President, CEO, Director
Signature
/s/ Rik J. Deitsch
Stock symbol
NPHC
Transactions as of
Nov 15, 2021
Transactions value $
$0
Form type
5
Date filed
1/14/2022, 04:16 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPHC Series B Preferred Stock Purchase +3M 3M Nov 15, 2021 Direct F1, F2
transaction NPHC Series B Preferred Stock Purchase +9M +300% 12M Nov 15, 2021 Direct F1, F3
holding NPHC Common Stock 43.3M Nov 15, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Series B preferred stock have no right of conversion to shares of common stock. Each share of Series B preferred stock is entitled to vote with the Corporation's common stock as a single class on all matters submitted to common stock holders to vote. Each share of Series B Preferred Stock is entitled to one thousand votes per share.
F2 3,000,000 shares of Series A Preferred Stock held by Mr. Deitsch were exchanged for an equal number of Series B Preferred Stock of the Company pursuant to a share exchange agreement between Rik Deitsch and the Company.
F3 9,000,000 shares of Series B Preferred Stock were issued in satisfaction of corporate debt owed by the Company to Mr. Deitsch pursuant to a resolution adopted by the board of directors of the Company.